Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial

Summary Background Angiotensin-converting enzyme inhibitors have been shown to reduce the risk of end-stage renal disease and death in non-transplant patients with proteinuria. We examined whether ramipril would have a similar beneficial effect on important clinical outcomes in kidney transplant rec...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet. Diabetes & endocrinology 2016-04, Vol.4 (4), p.318-326
Hauptverfasser:	Knoll, Greg A, Prof, Fergusson, Dean, Prof, Chassé, Michaël, MD, Hebert, Paul, Prof, Wells, George, Prof, Tibbles, Lee Anne, MD, Treleaven, Darin, MD, Holland, David, Prof, White, Christine, MD, Muirhead, Norman, Prof, Cantarovich, Marcelo, Prof, Paquet, Michel, MD, Kiberd, Bryce, Prof, Gourishankar, Sita, MD, Shapiro, Jean, Prof, Prasad, Ramesh, MD, Cole, Edward, Prof, Pilmore, Helen, MD, Cronin, Valerie, Hogan, Debora, Ramsay, Tim, PhD, Gill, John, Prof
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Angiotensin-Converting Enzyme Inhibitors - therapeutic use Double-Blind Method Endocrinology & Metabolism Female Follow-Up Studies Glomerular Filtration Rate Graft Rejection - drug therapy Graft Rejection - etiology Graft Survival Humans Kidney Failure, Chronic - surgery Kidney Function Tests Kidney Transplantation - adverse effects Male Middle Aged Other Postoperative Complications Prognosis Proteinuria - drug therapy Proteinuria - etiology Ramipril - therapeutic use Risk Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!